Discover the latest developments in myeloma research from the Annual American Society of Hematology meeting. Clinical trial investigators share their abstract presentations from ASH delving deep into the key research takeaways. Watch Now: https://lnkd.in/gaawhHcq #ASH23
International Myeloma Foundation’s Post
More Relevant Posts
-
#Congress | 🔎 What subjects were amplified by #HCPs through social media during #EHA2024? In June, took place the European Hematology Association (EHA) 2024 Hybrid Congress. The following pages provide a brief overview of the volume of conversations, the share of voice of clinical trials most discussed, or top hashtags. Moreover, discover a focus on #multiplemyeloma with the topics of discussions. Access the SML EHA2024 full report by clicking this link 👉 https://lnkd.in/e6-MYzHj
To view or add a comment, sign in
-
Mark your calendars for a live webinar hosted by Fortis Institute of Blood Disorder on Innovations in Hematology. Join us on May 17th, 2024, from 7 PM to 8 PM and gain invaluable knowledge from leading specialists Dr. Jayastu Senapati and Dr. Nikhil M Kumar. Discover new technologies and innovative practices that are shaping the future of hematology. #AtFortisWeCare #FortisHealthcare #Webinar
To view or add a comment, sign in
-
📢All 12 manuscripts in the #SpecialIssue “#Hematologic #Malignancies: Challenges from Diagnosis to Treatment”, led by Dr. Ioanna Sakellari and Dr. Eleni Gavriilaki, Hematology Department and Dr. Eleni Gavriilaki, have been published! 🎉🎉 📌You are welcome to read via the following link: https://lnkd.in/dyADYnGy
To view or add a comment, sign in
-
New publication 📝 Retrospective analysis published in Hematology provides new insights for #AcuteLymphoblasticLeukemia, see: https://loom.ly/vnLhcDM #ALLsm #leusm #MedEducation
To view or add a comment, sign in
-
NEW #Thalassemia Sessions from #ASH23🩸 💬 In this session, leading experts Maria Domenica Cappellini & Kevin Kuo discuss exciting updates in #thalassemia presented at the 2023 ASH Annual Meeting and Exposition The experts cover several topics, including the promise of novel #genetherapies, ongoing #clinicaltrials in the field, and the value of #precisionmedicine 🔬 Take a look 👉 https://lnkd.in/e2-JsM7Y #HemOnc #MPNsm American Society of Hematology
To view or add a comment, sign in
-
NEW #MPN Session from #ASH23🩸 💬 This EXCLUSIVE discussion features leading experts Ruben Mesa, MD, Claire Harrison & Jean-Jacques Kiladjian, who discuss key updates in the #treatment and #management of #myeloproliferativeneoplasms (#MPNs) following the 65th ASH Annual Meeting and Exposition The experts cover a variety of topics, including #novelagents being explored in essential #thrombocythemia (ET), updates in the treatment of #polycythemiavera (PV), and novel combinations being evaluated in #myelofibrosis (MF) 🔦 Take a look 👉 https://lnkd.in/eXeXjSFj #HemOnc #MPNsm American Society of Hematology
To view or add a comment, sign in
-
New phase III study 📝 A new publication in Annals of Hematology outlines current treatments and unmet needs for patients with early/lower-risk primary #myelofibrosis and details the design of a new phase III study of ropeginterferon alfa-2b in this population, see https://loom.ly/pE6XIK0 #MPN #MPNsm
To view or add a comment, sign in
-
Executive Vice-President and Chief Medical Officer, CLL Society, Inc., a 501c3 dedicated to the unmet needs of the chronic lymphocytic community (CLL)
Should be an informative webinar for patient and doctor alike who are invested in the latest research from ASH 2023 on CLL/SLL
Our ASH 2023 Comes to You webinar is one week away on Jan. 26th! Join CLL expert Dr. Nicole Lamanna and Dr. Brian Koffman as they discuss important CLL research and clinical trial data that was presented at the American Society of Hematology (ASH) Annual Meeting that took place in December 2023. Learn more and register at: https://bit.ly/3ROI3nQ
To view or add a comment, sign in
-
How can your laboratory help reduce unnecessary complications for newly diagnosed Multiple Myeloma patients? Find out how from Prof. Guy Pratt who discusses how your laboratory can help guide blood test requesting and appropriate hematology referral. Download our case studies from hospitals in the United Kingdom, United States and Spain by here: https://hubs.li/Q02phTNn0
To view or add a comment, sign in
-
In this article featured in AJMC - The American Journal of Managed Care, presenters from the 65th American Society of Hematology (ASH) Annual Meeting and Exposition discuss outcome disparities and the burden of multiple myeloma, which remains substantially higher among Black patients than White patients. Learn more!
To view or add a comment, sign in
8,975 followers